Ms Teresa Michelle Davis, CFY-SLP | |
110 Johnson Ln, Barbourville, KY 40906-1321 | |
(606) 546-5109 | |
(606) 546-4199 |
Full Name | Ms Teresa Michelle Davis |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 110 Johnson Ln, Barbourville, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194044628 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 10-022 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Teresa Michelle Davis, CFY-SLP 110 Johnson Ln, Barbourville, KY 40906-1321 Ph: (606) 546-5109 | Ms Teresa Michelle Davis, CFY-SLP 110 Johnson Ln, Barbourville, KY 40906-1321 Ph: (606) 546-5109 |
News Archive
Researchers in Japan and Canada have discovered a key component of the quality control mechanism that operates inside human cells - sometimes too well. The breakthrough has significant implications for the development of new treatments for cystic fibrosis (CF) and some other hereditary diseases, the researchers say. Their results were published July 25 in the journal Science.
In the current print edition, the Economist includes two articles examining different aspects of China's so-called "one-child policy." The first article looks at the effects of the country's shrinking working-age population, which the National Bureau of Statistics (NBS) recently announced "shrank last year by a total of 3.45 million," the magazine notes, adding, "The new statistics will amplify calls for reform of China's one-child policy."
The effect of advanced paternal age at childbearing on the psychiatric morbidity risk of their children extends to several psychiatric disorders and particularly bipolar disorder, findings from a sibling-comparison study show.
Use of the amino acid supplement L-arginine following a heart attack does not improve certain cardiac functions and measurements and may be associated with an increased risk of death, according to a study in the January 4 issue of JAMA: The Journal of the American Medical Association.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed enrollment of the first 40 subject cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.
› Verified 1 days ago
Mrs. Teresa Lynn Evans, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 65 Minton Hickory Farm Rd, Barbourville, KY 40906 Phone: 606-546-5136 | |
Donna Faye Martin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 259 Ky 225, Barbourville, KY 40906 Phone: 606-627-1990 | |
Carla J Jordan, M.A., CFY-SLP, ATP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 Johnson Lane, Ccshnc Barbourville, Barbourville, KY 40906 Phone: 606-546-5109 | |
Rebekah Mills, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Chestnut St, Barbourville, KY 40906 Phone: 606-627-1157 | |
Rebecca Smith, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 65 Minton Hickory Farm Rd, Barbourville, KY 40906 Phone: 606-546-5136 | |
Mrs. Rebecca Jean Long, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 Johnson Ln, Barbourville, KY 40906 Phone: 606-546-5109 |